Allergy and Immunology · San Jose, CA
NPI
1194733428
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
4050 Moorpark Ave
San Jose, CA, 95117
Phone (408) 243-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
17,164 services
Medicare patients, 2024
745
Average age 75
Drug cost, 2024
$1.3M
2,479 prescriptions
Company payments, 2025
$1,752
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James D Wolfe was code 95004 (test - miscellaneous), 8,515 times for 114 patients. In total James D Wolfe billed 17,164 services in 26 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-12-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 8,515 | 114 | $3.19 | $27K |
| 95165 Treatment - Miscellaneous | Office | 2,695 | 146 | $13.57 | $37K |
| 95117 Treatment - Miscellaneous | Office | 2,060 | 143 | $10.79 | $22K |
| 94010 Pulmonary Function Testing | Office | 833 | 507 | $23.50 | $20K |
| 95012 Pulmonary | Office | 793 | 481 | $17.41 | $14K |
| 99214 Office E&M - Established | Office | 781 | 479 | $104.18 | $81K |
| 95024 Test - Miscellaneous | Office | 458 | 73 | $7.56 | $3,462 |
| 99213 Office E&M - Established | Office | 258 | 235 | $70.61 | $18K |
| 95115 Treatment - Miscellaneous | Office | 160 | 15 | $8.44 | $1,351 |
| 99204 Office E&M - New | Office | 115 | 115 | $137.49 | $16K |
| 99203 Office E&M - New | Office | 45 | 45 | $84.49 | $3,802 |
| 99211 Office E&M - Established | Office | 15 | 13 | $22.83 | $342 |
| G0009 Administration of pneumococcal vaccine | Office | 14 | 14 | $37.80 | $529 |
| 90732 Vaccine Product | Office | 14 | 14 | $130.80 | $1,831 |
By year: 2022 $297K for 21,681 services; 2023 $272K for 18,938 services; 2024 $253K for 17,164 services.
Medicare prescription drug claims, 2024
In 2024, the drug James D Wolfe prescribed most often to Medicare patients was Azelastine Hcl, with 312 prescriptions and refills. In total James D Wolfe wrote 2,479 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Azelastine Hcl Generic | 312 | 642 | 133 | $15K |
| Hydroxyzine Hcl Generic | 293 | 652 | 125 | $11K |
| Ipratropium Bromide Generic | 254 | 538 | 106 | $12K |
| Montelukast Sodium Generic | 191 | 477 | 60 | $2,517 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 170 | 226 | 80 | $5,649 |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 150 | 322 | 36 | $141K |
| Prednisone Generic | 149 | 152 | 115 | $1,230 |
| Clarithromycin Generic | 135 | 148 | 105 | $7,453 |
| Dupixent Syringe Dupilumab | 104 | 112 | 11 | $402K |
| Alvesco Ciclesonide | 103 | 232 | 35 | $111K |
| Dupixent Pen Dupilumab | 95 | 99 | 12 | $379K |
| Triamcinolone Acetonide Generic | 59 | 75 | 29 | $283 |
| Fluticasone Propionate Generic | 42 | 105 | 15 | $6,248 |
| Arnuity Ellipta Fluticasone Furoate | 39 | 71 | Under 11 | $17K |
| Cromolyn Sodium Generic | 38 | 45 | 22 | $688 |
Brand drugs: - claims; generic drugs: 1,691 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James D Wolfe $1,752 ($1,752 in general payments such as food, travel and fees) from 17 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $753.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 30 | $753 |
| GlaxoSmithKline, LLC. GSK | 11 | $226 |
| ARS Pharmaceuticals Operations, Inc. SPRY | 17 | $212 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $168 |
| Genzyme Corporation SNY | 4 | $114 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $83.4 |
| CSL Behring CSL.AX | 2 | $54.69 |
| Paratek Pharmaceuticals, Inc. | 1 | $29.37 |
| Grifols USA, LLC | 1 | $28.32 |
| Pfizer Inc. PFE | 1 | $27.17 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.